Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006

Vaccine

Volumn 27, Issue 27, 2009, Pages 3553-3560

  Tyrrell, Gregory J ^a,b   Lovgren, Marguerite ^a   Chui, Natalie ^a   Minion, Jessica ^b   Garg, Sipi ^d   Kellner, James D ^c   Marrie, Thomas J ^b  

^a National Centre for Streptococcus   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antimicrobials; Canada; Conjugate vaccine; Invasive disease; Serotype changes; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN PHOSPHATE; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CANADA; CHILD; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREND STUDY;

ADOLESCENT; ADULT; AGED; CANADA; CHILD; CHILD, PRESCHOOL; ERYTHROMYCIN; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 67349107021     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.063     Document Type: Article

References (30)

1. Fedson D.S., and Scott J.A.G. The burden of pneumococcal disease among adults in developed and developing countries: what is said and is not known. Vaccine 17 Suppl. 1 (1999) S11-18
2. Williams B.G., Gouws E., Boschi-Pinto C., Bryce J., and Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2 1 (2002) 25-32
3. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 33 10 (1995) 2759-2762
4. Park I.H., Pritchard D.G., Cartee R., Brandao A., Brandileone M.C., and Nahm M.H. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 45 4 (2007) 1225-1233
5. National Advisory Committee on Immunization. Canadian immunization guide. 7th ed. (2006), Public Health Agency of Canada, Ottawa, ON
6. Alberta Health and Wellness, Health Surveillance. Population Projections for Alberta and its Health Regions, 2000-2030. January 2001.
7. Canada Communicable Disease Report. Case definitions for diseases under National Surveillance-Health Canada. May 2000; 26S3:51.
8. Facklam R.R., and Washington J.A. Streptococcus and related catalase-negative gram-positive cocci. In: Balows A., Hausler Jr. W.J., Herrmann K.L., Isenberg H.D., and Shadomy H.J. (Eds). Manual of clinical microbiology. 5th ed. (1991), American Society for Microbiology, Washington, DC 238-257
9. Lund R., and Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In: Bergan T., and Norris J.R. (Eds). Methods in microbiology vol. 12 (1978), Academic Press, Inc., New York, NY 241-262
10. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing; fifteenth informational supplement (2005), Clinical Laboratory Standards Institute, Wayne, PA [CLSI document M100-S15]
11. National Committee for Clinical Laboratory Standards. Methods for dilution susceptibility testing for bacteria that grow aerobically; approved standard. 6th ed. (2003), National Committee for Clinical Laboratory Standards, Wayne, PA [NCCLS document M7-A6]
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement (2003), National Committee for Clinical Laboratory Standards, Wayne, PA [NCCLS document M100-S12]
13. Sutcliffe J., Grebe T., Tait-Kamadt A., and Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40 11 (1996) 2562-2566
14. Park I.H., Moore M.R., Treanor J.J., Pelton S.I., Pilishvili T., Beall B., et al. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 198 12 (2008) 1818-1822
15. Tyrrell G.J., Lovgren M., Kellner J.D., Patrick D., Virani S., Horsman G., et al. Outbreak of Streptococcus pneumoniae serotype 5 in Western Canada. 2nd annual public health agency of Canada (PHAC) research forum. March 12-13, Winnipeg, Manitoba (2007) [abstract no. P-43]
16. Twele L.G., Tyrrell G.J., Vanderkooi O.G., Macdonald J., Church D., Scheifle D., et al. Large outbreak of serotype 5 invasive pneumococcal disease in predominantly homeless persons in Calgary, Canada. 47th interscience conference on antimicrobial agents and chemotherapy (ICAAC). September 17-20, Chicago, IL, USA (2007) [abstract no. L-1155]
17. Tyrrell G.J., Lovgren M., Kellner J.D., Grimsrud K., Hoang L., Patrick D., et al. A large outbreak of invasive Streptococcus pneumoniae serotype 5 in western Canada. 6th international symposium on pneumococci and pneumococcal diseases (ISPPD), 2008. June 8-12, Reykjavik, Iceland (2008) [abstract no. S05-O3]
18. Waites K., Johnson C., Gray B., Edwards K., Crain M., and William Jr. B. Use of clindamycin disks to detect macrolide resistance mediated by erm(B) and mefE in Streptococcus pneumoniae isolates from adults and children. J Clin Microbiol 38 5 (2000) 1731-1734
19. Zhong P., Cao Z., Hammond R., Chen Y., Beyer J., Shortridge V.D., et al. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides. Microb Drug Resist 5 5 (1999) 183-188
20. Santagati M., Iannelli F., Oggioni M.R., Stefani S., and Pozzi G. Characterization of a genetic element carrying the IV efflux gene, mefA, in Streptococcus pneumoniae. Antimicrob Agents Chemother 44 9 (2000) 2585-2587
21. Sutcliffe J., Karnradt-Tait A., and Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistance to macrolides but sensitive to clindamycin, a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 40 8 (1996) 1817-1824
22. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196 9 (2007) 1346-1354
23. Centers for Disease Control and Prevention. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae-Massachusetts, 2001-2006. MMWR Surveill Summ 56 41 (2007) 1077-1080
24. Moore M.R., Gertz Jr. R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197 7 (2008) 10116-10127
25. Kellner J.D., Church D.L., MacDonald J., Tyrrell G.J., and Scheifle D.W. Progress in the prevention of pneumococcal infection: the calgary area Streptococcus pneumoniae epidemiology research (CASPER) study. CMAJ 173 10 (2005) 1149-1151
26. Kyaw M.H., Lynfield R., Schaffner W., Carig A.S., Hadler J., Reingold A., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 14 (2006) 1455-1463
27. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 18 (2003) 1737-1746
28. Jacobs M.R., Good C.E., Beall B., Bajaksouzian S., Windau A.R., and Whitney C.G. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J Clin Microbiol 46 3 (2008) 982-990
29. Stephens D.S., Zughaier S.M., Whitney C.G., Baughman W.S., Barker L., Gay K., et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine; population-based assessment. The Lancet 365 9462 (2005) 855-863
30. Wierzbowski A.K., Nichol K., Laing N., Hisanaga T., Nikulin A., Karlowsky J.A., et al. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian respiratory Organism Susceptibility Study (CROSS) (1998-2004). J Antimicrob Chemother 60 4 (2007) 733-740